Skip to Main Content
Menu Button
Company
About
Team
Contact
News
News
Press Releases
September 6, 2023
Apollo Therapeutics Closes $226.5 Million Series C Financing Led by Patient Square Capital
November 14, 2022
Apollo Therapeutics and The Institute of Cancer Research enter into collaboration for cancer drug development
August 1, 2022
Avalo Therapeutics Transfers Anti-IL-18 Antibody, AVTX-007 (camoteskimab) to Apollo Therapeutics
Load More
Recent Press
August 1, 2022
Apollo lands inflammatory antibody from Avalo for $90M biobucks
Endpoints | June 17, 2021
A UK biotech looks to bring alliance between GSK, J&J, AstraZeneca, and top universities stateside with its first megaround
Fiercebiotech | June 17, 2021
Apollo Therapeutics to go ‘full throttle’ with $145M raise after 5 years under the radar
Load More
